U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07034898) titled 'Dexmedetomidine vs Labetalol for Airway Stress in Hypertensive Craniotomy Patients' on June 15.
Brief Summary: This randomized trial compares dexmedetomidine and labetalol in controlling airway and hemodynamic stress during extubation in hypertensive patients undergoing craniotomy. Outcomes include extubation quality, vital signs, sedation, and adverse effects.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Airway Stress Response
Intervention:
DRUG: Dexmedetomidine
Participants in this arm will receive dexmedetomidine at a dose of 0.5 mcg/kg, diluted with normal saline to a total volume of 50 mL. The solutio...